Correlation Between INmune Bio and Cassava Sciences
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Cassava Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Cassava Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Cassava Sciences, you can compare the effects of market volatilities on INmune Bio and Cassava Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Cassava Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Cassava Sciences.
Diversification Opportunities for INmune Bio and Cassava Sciences
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between INmune and Cassava is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Cassava Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cassava Sciences and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Cassava Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cassava Sciences has no effect on the direction of INmune Bio i.e., INmune Bio and Cassava Sciences go up and down completely randomly.
Pair Corralation between INmune Bio and Cassava Sciences
Given the investment horizon of 90 days INmune Bio is expected to generate 0.18 times more return on investment than Cassava Sciences. However, INmune Bio is 5.41 times less risky than Cassava Sciences. It trades about -0.3 of its potential returns per unit of risk. Cassava Sciences is currently generating about -0.2 per unit of risk. If you would invest 630.00 in INmune Bio on August 30, 2024 and sell it today you would lose (141.00) from holding INmune Bio or give up 22.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
INmune Bio vs. Cassava Sciences
Performance |
| Timeline |
| INmune Bio |
| Cassava Sciences |
INmune Bio and Cassava Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INmune Bio and Cassava Sciences
The main advantage of trading using opposite INmune Bio and Cassava Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Cassava Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cassava Sciences will offset losses from the drop in Cassava Sciences' long position.| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
| Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |